Possible Treatment of End-Stage Hyperammonemic Encephalopathy by Inhibition of Glutamine Synthetase

Metabolic Brain Disease - United States
doi 10.1007/s11011-012-9338-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC